👁 1
💬 0
📄 Extracted Text (1,033 words)
From: ehbarak
To: "Jeffrey E." <[email protected]>
Subject: Re:
Date: Thu, 11 Aug 2016 14:46:54 +0000
I'll call in an hour.
Best
EB
Sent from my iPhone
On 11 Aug 2016, at 17:08, jeffrey E. <[email protected]> wrote:
On Thursday, August 11, 2016, ehbarak wrote:
Hi Jeff
Can we talk over the phone? What #?
Best
EB
Sent from my iPhone
On 11 Aug 2016, at 03:58, Jeffrey E. <[email protected]> wrote:
Re: Levitection.
As I indicated previously, the terms that were initially presented to us in a draft term sheet are summarized
in my June 22 email to you below. There are changes from the term sheet described in my previous email
to you below that I found in the current draft Share Purchase Agreement,the Share Rights Agreement and
the Amended and Stated Bylaws that include the following:
I. Instead of $2.19 per share, now the purchase price is $21.86 per share, though the Purchase Agreement
provides for the same aggregate of $1,020,000 and $680,000 of funding tranches and same post closing
shareholding percentages — That is, 27.30% of outstanding after first $1,020,000 investment tranche and
then 38.5% of outstanding after $680,000 investment tranche.
2. The automatic conversion of the preferred share that was initially stated in the term sheet to occur
upon a qualified IPO of no less than $50 MM in gross proceeds that nets $I0MM of proceeds, now will not
occur unless there is a qualified IPO of $80MM gross proceeds that nets $20MM of proceeds.
3. The 6% liquidation preference per share that was initially stated in the term sheet to terminate once the
preferred holders received distributions of 2 times the purchase price for their shares, no will not terminate
until the preferred holders receive 3.5 times the purchase price for their shares.
4. The bring along rights that in the term sheet were initially effective only upon 60% shareholder
approval of a transaction with a pre-money valuation of not less than $50MM, now may be imposed even if
the pre-money valuation is less than $50MM as long as there is 75% shareholder approval. That is to say,
bring along rights are imposed if if there is 60% shareholder approval of a transaction with a pre-money
EFTA00822000
valuation of not less then $50MM or if there is 75% shareholder approval of a transaction with a pre-money
valuation of less than $50MM.
Because there is missing information, I cannot give you a full summary of the deal as currently drafted. For
example:
I understand from the email we previously received that transmitted the signed term sheet to us that there
were certain changes to be made to the warrants. Specifically, the 25% increase in the exercise price of the
warrants was not to take effect unless either the first warrant for $1,500,000 was exercised by us or there
was a subsequent round of equity financing of at least $1MM where the purchase price per share in that
round was at least 25% higher than the purchase price in our round. However, the documents provided to
me include only a reference to the warrants to be issued in the transaction as being on schedules to the
Share Purchase Agreement and does not include the schedules or the full terms of the warrants. So, I have
no idea of what the terms are for warrants. There is a vague reference in the purchase agreement to a First
Warrant for $1,500,000, but nothing else about the terms of that warrant and nothing about the other
warrant (which the term sheet says is supposed to be for another $2MM, but I cannot not verify).
The other big problem is that, in addition to the omission of the schedules containing the forms and terms
of the warrants, no other schedules have been provided to us, including:
The schedule of milestones that trigger obligation to fund second tranche of $680K in no more than 9
month.
Board Resolutions
Shareholder Resolutions
CEO Compliance Certificate
Legal Opinion
Director Indemnification Agreements
Services Agreement of Gideon Levita
Employment Agreement of Raviv Levita
Consulting Agreement of Ehud Barak
Founders Repurchase Agreements
Cap Table
Reviewed but not audited Financial Statements
Business Plan and Budget
Form of Non-Comp, Non-Solicitation and Confidentiality Agreements
Form of Employment Agreements
Disclosure Schedule, which includes the lists of exceptions to the representations and warranties of
the Company. The disclosure schedule that is missing includes:
list of options granted
contracts, agreements and commitments list
list of related party transactions
list of officers and directors prior to closing
schedule of real property and tangible assets
IP Schedule
Product Schedule
Royalty Payment Obligations
Open Source Materials used
Schedule of liabilities
Exceptions to Absence of Changes from Delivered Financial Statements
Employee list
List of Employment, contractor and consultant agreements
List of employment, contractor and consultant agreements not terminable at will upon 30 days notice
without liability
EFTA00822001
List of government finding, government or university resources, or other person funding used to
develop IP
List of employees, contractors, consultants that were affiliated with Govt or universities, etc.
List of Brokers entitled to be paid for this transaction
List of Insurance Policies
List of laws not complied with
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00822002
ℹ️ Document Details
SHA-256
322ba73acd31b0d38da12c70b362c20323506019c64c4be9408af997c5055556
Bates Number
EFTA00822000
Dataset
DataSet-9
Type
document
Pages
3
💬 Comments 0